Collectively, these findings suggest that re-activation of key tumor suppressor genes following RING1A/RING1B/BMI1 inhibition may be a therapeutic strategy to inhibit cancer stem-cell proliferation and/or induce cell death (Figure 2B). Here, RNF2 is linked to cancer.